– Event to be held on Friday, September 9th, at 8 a.m. EDT – Philadelphia, Pennsylvania and Oxford, United Kingdom–(Newsfile Corp. – August 25, 2022) – Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, will ...
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) announced today that the Toronto Stock Exchange (the “Exchange”) has accepted a notice filed by VitalHub of its intention to make a Normal Course ...
Toronto, Ontario–(Newsfile Corp. – August 25, 2022) – VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) announced today that the Toronto Stock Exchange (the “Exchange”) has accepted a notice filed by VitalHub of its intention to make a Normal Course ...
Toronto, Ontario–(Newsfile Corp. – August 18, 2022) – LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (“LevelJump” or the “Company”), a Canadian leader in B2B telehealth solutions, is pleased to announce today it has reported financial results for the ...
Vancouver, British Columbia–(Newsfile Corp. – August 18, 2022) – Kovo HealthTech Corporation (TSXV: KOVO) (the “Company” “Kovo”) — a leader in healthcare technology and Billing-as-a-Service — is pleased to announce the results of its 2022 Annual General and Special Meeting ...
Vancouver, British Columbia–(Newsfile Corp. – August 17, 2022) – Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) (“APC” or the “Company”), is pleased to announce that its US subsidiary, Advanced Proteome Therapeutics Inc. (“APTI”), has had its technology featured in a ...
PathogenDx Receives Rank No. 1232 Among America’s Fastest-Growing Private Companies Scottsdale, Arizona–(Newsfile Corp. – August 16, 2022) – Inc. revealed that PathogenDx (“PathogenDx” or “Company”), a leader in world-class microarray technology to advance molecular testing in human diagnostics, food and ...
-Planning a New Approach to Treat Alzheimer’s Disease- Las Vegas, Nevada–(Newsfile Corp. – August 4, 2022) – TRINITY RESOURCES INC. (OTC Pink: TRRI) (the “Company” or “Trinity”) is pleased to announce that following approval by a super majority of Alzex ...
– Reaffirming financial guidance; Company funded into early 2024 – – ASCO data confirms afami-cel potential for synovial sarcoma; BLA submission on-track for Q4 2022 – – Update from signal-finding Phase 1 SURPASS trial at the September ESMO 2022 Congress ...
Vancouver, British Columbia–(Newsfile Corp. – August 3, 2022) – Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) (“APC” or the “Company”) is pleased to announce that the United States Patent and Trademark Office has issued a patent to its US subsidiary, Advanced Proteome ...